The effect of CPAP withdrawal on blood pressure in OSA: Data from three randomised-controlled trials

E. I. Schwarz, C. Schlatzer, V. A. Rossi, C. Nowak, K. E. Bloch, J. R. Stradling, M. Kohler (Zurich, Switzerland; Oxford, United Kingdom)

Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Session: The story continues: impact of OSA on cardiometabolic parameters
Session type: Poster Discussion
Number: 1740
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. I. Schwarz, C. Schlatzer, V. A. Rossi, C. Nowak, K. E. Bloch, J. R. Stradling, M. Kohler (Zurich, Switzerland; Oxford, United Kingdom). The effect of CPAP withdrawal on blood pressure in OSA: Data from three randomised-controlled trials. Eur Respir J 2014; 44: Suppl. 58, 1740

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The micro-RNA hsa-miR-502-3p is down-regulated in the plasma of obstructive sleep apnea patients after 2 weeks of continuous positive airway pressure therapy withdrawal: Data from a randomized controlled trial
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



Autoregulation versus defaecation: An unusual side effect of CPAP
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


The effect of positive airway pressure on cholesterol in patients with sleep apnea: Data from the European Sleep Apnea Network (ESADA)
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Effect of continuous positive airway pressure on blood pressure and the metabolic profile of women with obstructive sleep apnoea. A randomized-controlled trial
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016



A case series of CPAP therapy – Who declines treatment?
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

A randomized controlled trial of auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ)
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016

Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Adherence to continuous positive airway pressure therapy (CPAP) in patients with obstructive sleep apnea (OSA) in an Asian privately funded healthcare system
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Sleep quality and duration in patients with chronic heart failure and sleep disordered breathing
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Evaluation of the apnea-hypopnea index determined by adaptive-servo ventilation devices in heart failure patients with sleep disordered breathing
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014


Impact of continuous positive airway pressure on liver injury induced by obstructive sleep apnea: Data from randomized controlled trials
Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing
Year: 2015


Oscillating positive airway pressure (O-PAP) vs CPAP treatment in patients with obstructive sleep apneas
Source: International Congress 2014 – The technical and diagnostic agenda in OSA
Year: 2014

Continuous positive airway pressure (CPAP) supported by telemedicine improves sleepiness and quality of life but not blood pressure in high cardiovascular risk obstructive sleep apnea (OSA): A randomized, controlled trial
Source: Annual Congress 2013 –Ask, see and do: old and new technology in sleep disordered breathing
Year: 2013


Predictors of titrating pressure using A-CPAP in obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


Prediction of therapeutic effectiveness of nocturnal oxygen supplementation in Cheyne-Stokes breathing
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014

The effect of continuous positive airway pressure therapy on endothelial function in obstructive sleep apnea: A systematic review and meta-analysis
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014

The effect of CPAP on blood pressure in patients with OSAS and resistant hypertension followed 1 year
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015